We are live on ! Find out more
ACM

AH Capital Management Portfolio holdings

AUM $1.29B
1-Year Est. Return 26.81%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
-26.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$745M
AUM Growth
-$393M
Cap. Flow
-$537M
Cap. Flow %
-72.03%
Top 10 Hldgs %
99.85%
Holding
14
New
1
Increased
1
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
CAMP icon
CAMP4 Therapeutics
CAMP
+$17.5M
2
BIOA
BioAge Labs
BIOA
+$3.78M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$444M
2
CART icon
Maplebear
CART
+$114M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.95%
2 Technology 35.03%
3 Healthcare 25.22%
4 Industrials 2.48%
5 Real Estate 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DASH icon
1
DoorDash
DASH
$80.4B
$268M 35.95%
1,597,010
– –
IOT icon
2
Samsara
IOT
$20.8B
$175M 23.42%
3,995,652
– –
RVMD icon
3
Revolution Medicines
RVMD
$40B
$120M 16.13%
2,748,523
– –
XYZ
4
Block Inc
XYZ
$47.6B
$86.4M 11.59%
1,016,697
– –
NAUT icon
5
Nautilus Biotechnolgy
NAUT
$213M
$29.7M 3.98%
17,653,917
– –
BIOA
6
BioAge Labs
BIOA
$970M
$18.7M 2.51%
3,233,170
+219,195
+7% +$3.78M
ACCD
7
DELISTED
Accolade Inc
ACCD
$18.5M 2.48%
5,398,708
– –
CAMP icon
8
CAMP4 Therapeutics
CAMP
$181M
$11.1M 1.49%
+2,125,339
New +$17.5M
OPEN icon
9
Opendoor
OPEN
$3.68B
$9.92M 1.33%
6,407,515
– –
ERAS icon
10
Erasca
ERAS
$6.68B
$7.18M 0.96%
2,862,500
– –
DNA icon
11
Ginkgo Bioworks
DNA
$486M
$1.07M 0.14%
108,568
– –
CYN icon
12
Cyngn
CYN
$16M
$48.9K 0.01%
384
– –
CART icon
13
Maplebear
CART
$10.4B
– –
-2,802,058
Closed -$114M
HOOD icon
14
Robinhood
HOOD
$84.6B
– –
-18,954,860
Closed -$444M

Similar funds

PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
ACM
Alta Capital Management Salt Lake City, Utah $1.29B AUM 17.57% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
MA
MONECO Advisors Fairfield, Connecticut $1.29B AUM 18.01% 1-Year Est. Return
CTA
Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return

AH Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, AH Capital Management held 14 positions worth $745M, down 34% from $1.14B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AH Capital Management withdrew a net $537M in Q4 2024, closing 2 positions. Its most notable exit was Robinhood, an estimated $444M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, AH Capital Management opened a new position in CAMP4 Therapeutics worth $11.1M.

  • AH Capital Management's largest Q4 2024 buy was CAMP4 Therapeutics: 2,125,339 shares worth $11.1M.
  • AH Capital Management added most to BioAge Labs in Q4 2024, an estimated $3.78M increase.
  • AH Capital Management fully exited Robinhood in Q4 2024, selling an estimated $444M.
  • AH Capital Management's ten largest holdings make up 100% of its $745M portfolio in Q4 2024.
  • AH Capital Management opened 1 new position and closed 2 in Q4 2024.
  • AH Capital Management's portfolio value fell 34% quarter-over-quarter to $745M.

Based on AH Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.